HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.

10th Edition of International Conference on Neurology and Brain Disorders

October 21-23, 2024

October 21 -23, 2024 | Baltimore, Maryland, USA

INBC 2024

Speaker at Brain Disorders Conference - Thomas J Webster
Keynote Presentation (In-Person)
Thomas J Webster, Interstellar Therapeutics, United States

Nanomedicine is the use of nanomaterials to improve disease prevention, detection, and treatment which has resulted in hundreds of FDA approved medical products. While nanomedicine has been around for several decades, new technological advances are pushing its boundaries. For exa [....] » Read More

Speaker at Neurology Conferences - Yan M Yufik
Keynote Presentation (In-Person)
Yan M Yufik, Virtual Structures Research, Inc, United States

Aristotle’s “Metaphysics” starts with a pronouncement “Humans desire to understand”, establishing understanding capacity as the defining characteristic of human intellect separating humans from the other species. Throughout history, cognitive capacit [....] » Read More

Speaker at Neuroscience Conference - Roger H Coletti
Keynote Presentation (In-Person)
Roger H Coletti, Interventional Health, PA, United States

It has been noted by multiple researchers that there is Spontaneous Electrical Activity (SEA) at painful trigger points. This author has studied chronic muscle spasm and found that SEA is always present and appears to be the cause for the chronic nature of muscle spasm and result [....] » Read More

Speaker at Brain Disorders Conference - Jag H Khalsa
Oral Presentation (In-Person)
Jag H Khalsa, GWU School of Medicine and Health Sciences, United States

Cannabis is the most used illegal drug in the world with an estimated 2.5% of the world’s population (180 million) using it regularly (World Drug Report 2017)1. Medicinal and/or recreational cannabis use is associated with significant health consequences) (WHO, 20162; Volko [....] » Read More

Speaker at Neuroscience Conference - Nazanin Azizi
Oral Presentation (In-Person)
Nazanin Azizi, University of California Davis, United States

Background: Cerebral venous sinus thrombosis (CVST) is a potentially life-threatening condition with a wide range of clinical presentations from localized headache (the most common symptom) to mental status disturbances, seizure and coma. The main purpose of this study is to eval [....] » Read More

Speaker at Brain Disorders Conference - Erwin L J Roggen
Oral Presentation (In-Person)
Erwin L J Roggen, ToxGenSolutions BV, Netherlands

ToxGenSolutions is a biotech company focused on developing novel and innovative methods to drive the discovery of impactful and personalized early-stage diagnostics and therapeutics with focus on prevention of chronic disease (Alzheimer’s disease, pain syndromes and long-CO [....] » Read More

Speaker at Neurology Conferences - Kineret Sharfi
Oral Presentation (In-Person)
Kineret Sharfi, Ben-Gurion University, Israel

The literature describes a close relationship between cognitive executive functions and daily activity. Adults with specific learning disabilities (SLDs) (e.g., dyslexia, dysgraphia, and dyscalculia) reveal limitations in daily activity in various life domains including decreased [....] » Read More

Speaker at Neuroscience Conference - Raul V Rodriguez
Oral Presentation (In-Person)
Raul V Rodriguez, Woxsen University, India

Necrobotics 360: Shaping the Future of Healthcare" presents a transformative vision where cutting-edge artificial intelligence (AI) technologies converge with healthcare, redefining the future of medical practices. It is an innovative approach that integrates AI, machine lea [....] » Read More

Speaker at Neuroscience Conference - Mohamad Sultan Khan
Oral Presentation (In-Person)
Mohamad Sultan Khan, University of Hyderabad, India

During the course of evolution and earth’s rotation round its axis, the surface inhabitants are exposed to daily a predictable light and dark condition which impose specific demands on the physiology and influences the behaviour of an organism. Such cyclic patterns in the p [....] » Read More

Speaker at Neurology Conferences - Shristi Shakya
Oral Presentation (In-Person)
Shristi Shakya, Manipal College of Health Professions, India

Background and objectives: A delay in achieving head and trunk control can present numerous challenges in the activities of daily living for children with Cerebral Palsy (CP). This frequently require extended therapy, which may become repetitive, leading to decreased engagement i [....] » Read More

Speaker at Neurology Conferences - Dominique Smith
Poster Presentation (In-Person)
Dominique Smith, Loma Linda University Education & Health Consortium, United States

We present a case of a 43-year-old patient with a past medical history of intravenous drug abuse who presented with one month of numbness, pain, and paresthesia localized to the left posterior forearm and dorsum of hand. The patient also endorsed subjective weakness affecting gri [....] » Read More

Speaker at Neuroscience Conference - Asma Mohammadi
Poster Presentation (In-Person)
Asma Mohammadi, UPMC Mercy, United States

Background: Kratom is an herbal supplement derived from the Asian plant Mitragyna speciosa and is predominantly used for self-treating pain or mood disorders in the United States. However, recent evidence suggests it is being increasing used as an alternative to buprenorphin [....] » Read More

Speaker at Neuroscience Conference - Puja Punukollu
Poster Presentation (In-Person)
Puja Punukollu, Augusta University, United States

Neurological disorders, comprising conditions like dementia, migraines, and stroke, pose significant health challenges globally. In the digital age, individuals increasingly turn to online platforms for health information. Given the intricate nature of neurological conditions, ev [....] » Read More

Speaker at Brain Disorders Conference - Mary Avella
Poster Presentation (In-Person)
Mary Avella, Hunter College, United States

Autism Spectrum Disorder is a neurological disorder that affects how a person communicates and interacts with others. One way people on the spectrum are different from neurotypical people is in their attentional focus. In particular, those on the spectrum have been shown to pay c [....] » Read More

Speaker at Neurology Conferences - Michael Sulaiman
Poster Presentation (In-Person)
Michael Sulaiman, Edward Via College of Osteopathic Medicine, United States

Normal pressure hydrocephalus is a rare neurologic disorder primarily impacting older adults, classically presenting with clinical triad of gait dysfunction, cognitive impairment, and urinary incontinence, in addition to hydrocephalus on brain imaging. Normal pressure hydrocephal [....] » Read More

Speaker at Brain Disorders Conference - Rikesh Shrestha
Poster Presentation (In-Person)
Rikesh Shrestha, Sentara Health, United States

Background and objectives: Persons with stroke often encounter challenges in ambulation due to impaired motor function and coordination. The aftermath of stroke can significantly affect a person’s ability to ambulate independently, necessitating tailored intervention for re [....] » Read More

Speaker at Neuroscience Conference - Amaan Javed
Poster Presentation (In-Person)
Amaan Javed, University of Delhi, India

Introduction: Apoptosis is a form of programmed cell death, that underlies the wide range of symptoms investigated in neurological disorders from stroke to neurodegenerative diseases such as Alzheimer’s. Caspases are shown to be capable of producing inflammasomes along [....] » Read More

Speaker at Neurology Conferences - Naranchimeg Gendendagva
Poster Presentation (In-Person)
Naranchimeg Gendendagva, The Third State Central Hospital of Mongolia, Mongolia

Cerebral venous thrombosis is a rare neurological disorder that can be diagnosed clinically and neuro-radiologically. The prognosis of this disease is good in most cases. However, if it is complicated by a stroke, it can lead to death or disability. Cerebral vein thrombosis accou [....] » Read More

Speaker at Neurology Conferences - Mohinish S
Oral Presentation (In-Person)
Mohinish S, Madras Medical College, India

Autoimmune Encephalitis (AIE) is closely associated with antibodies against neuronal cell-surface proteins, receptors, and ion channels. However, some forms of disorder have no known antibody presently. In children neurological manifestations are prominent initial presentation as [....] » Read More

Speaker at Brain Disorders Conference - Lowrence Precious C Dichoso
Oral Presentation (In-Person)
Lowrence Precious C Dichoso, University of the Philippines, Philippines

Background: Guillain-Barre syndrome (GBS) commonly presents with progressive ascending weakness of the extremities and can also present with dysautonomia, that is associated with longer hospital stay and higher mortality rates than those without dysautonomia. Objectives: Our s [....] » Read More

Speaker at Brain Disorders Conference - Nahom
Oral Presentation (In-Person)
Nahom, FelgeHiwot Referal Hospital, Ethiopia

The COVID-19 pandemic has caused an unprecedented impact on global health, affecting millions of people worldwide. In effect to tackling the devastating outcomes of the disease, the development of vaccines was the primary focus of health researchers worldwide. Thus, a f [....] » Read More

Speaker at Neuroscience Conference -  Afsaneh Nikjooy
Oral Presentation (In-Person)
Afsaneh Nikjooy, Iran University of Medical Sciences, Iran (Islamic Republic of)

Background: Dyssynergic defecation (DD) is a major cause of chronic functional constipation. Patients with DD have greater psychological distress and impaired health-related quality of life compared with the general population. This study aimed to evaluate the effectiveness of co [....] » Read More

Speaker at Neurology Conferences - Mana Ahmadianghalehsorkh
Oral Presentation (In-Person)
Mana Ahmadianghalehsorkh, Kashani Comprehensive Epilepsy Center, Iran (Islamic Republic of)

More than 20 new anti-seizure medications have been approved by the FDA in the past 3 decades; however, epilepsy remains drug resistant in up to 40% of patients. The probability of achieving seizure freedom declines rapidly after two adequate doses of anti-seizure medication, and [....] » Read More

Speaker at Neurology Conferences - Elham Azimzadeh
Oral Presentation (In-Person)
Elham Azimzadeh, Shahid Beheshti University, Iran (Islamic Republic of)

Children with cerebral palsy (CP) have weak physical abilities and their limitations may have an effect on performing everyday motor activities. One of the most important and common debilitating factors in CP is the malfunction in the upper extremities to perform motor skills and [....] » Read More

Speaker at Neurology Conferences - Olga Germanova
Oral Presentation (In-Person)
Olga Germanova, Samara State Medical University, Russian Federation

Background: Up to 45% of ischemic strokes are cryptogenic. Aim of our investigation is to study the heart arrhythmias in patients with cryptogenic stroke. Subjects and methods: In our investigation we observed 52 patients 1 month and more after the cryptogenic stroke. In [....] » Read More

Speaker at Neuroscience Conference - Yuxiang Chen
Oral Presentation (In-Person)
Yuxiang Chen, The People's Hospital of Changshou District, China

Objective: This experiment aims to systematically review the recent advances in the treatment of acute post-circulatory progressive ischemic stroke using novel thrombolytic drugs. Additionally, it explores the future research trends to provide a scientific foundation for enhancin [....] » Read More

Speaker at Neuroscience Conference - Farshid Alazmani-Noodeh
Oral Presentation (In-Person)
Farshid Alazmani-Noodeh, AJA University of Medical Sciences, Iran (Islamic Republic of)

Background and Aim: Stroke is the most common cause of cerebrovascular disease, the third leading cause of death and the second leading cause of disability in developed countries, leading to physical, sensory, cognitive, psychological, functional and social changes in individuals [....] » Read More

Speaker at Brain Disorders Conference - Ayesha Younis
Poster Presentation (In-Person)
Ayesha Younis, Tianjin University, China

A brain tumor is a distorted tissue wherein cells replicate rapidly and indefinitely, with no control over tumor growth. Deep learning has been argued to have the potential to overcome the challenges associated with detecting and intervening in brain tumors. It is well establishe [....] » Read More

Speaker at Brain Disorders Conference - Frances Eunice B Alcober
Poster Presentation (In-Person)
Frances Eunice B Alcober, Remedios Trinidad Romualdez Hospital, Philippines

Introduction: Acute Ischemic Stroke (AIS) is a medical emergency that affects people globally. In the Philippines, it remains as the third leading cause of mortality due to delays in its identification and lack of prognostic materials. This study aims to determine the use of plat [....] » Read More

Speaker at Neurology Conferences - Pantea Sazegar
Poster Presentation (In-Person)
Pantea Sazegar, University of Arizona College of Medicine - Tucson, United States

Introduction: Fingolimod is an FDA-approved oral disease-modifying therapy for relapsing-remitting forms of multiple sclerosis and works through inhibition of lymphocyte egress from secondary lymphoid organs, reducing circulating levels of lymphocytes. While Fingolimod, and [....] » Read More

Speaker at Neurology Conferences - Zuber Khan
Poster Presentation (In-Person)
Zuber Khan, ISF College of Pharmacy, India

Multiple sclerosis (MS) is a debilitating, inflammatory and demyelinating disease of the central nervous system influenced by environmental and genetic factors. Around 2.8 million people worldwide are affected in MS due to its challenging diagnosis and treatment. Our study invest [....] » Read More

Speaker at Neuroscience Conference - Ken Ware
Keynote Presentation (Virtual)
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia

NeuroPhysics Therapy (NPT) is a fascinating field that delves into the discrete functionality and behaviour of the human nervous system. It explores how our nervous system perceives and responds to the environment, and through the development and application of specialized techni [....] » Read More

Speaker at Neuroscience Conference - W S El Masri
Keynote Presentation (Virtual)
W S El Masri, Keele University, United Kingdom

  The incidence of Traumatic spinal cord injuries (TSCI) is small and ranges between 10-50/million population/year. Prior to the second WW the great majority of patients died within two years of injury. Since the 2nd WW, due to the efforts of the pioneers who dedicated th [....] » Read More

Speaker at Brain Disorders Conference -  Irene Fasciani
Oral Presentation (Virtual)
Irene Fasciani, University of L'Aquila, Italy

(+)-4-Propyl-9-hydroxynaphthoxazine ((+)PHNO) is a high affinity agonist at dopamine D3 and, less potently, D2 receptors. In the nineteen eighties and nineties, this naphthoxazine compound was amongst the most promising, non-ergot derivatives in the pipeline for the treatment of [....] » Read More

Speaker at Brain Disorders Conference - Sachin N Nair
Oral Presentation (Virtual)
Sachin N Nair, Amrita Institute of Medical Sciences & Research Center, India

Background: With no randomised controlled trials or consensus guidelines for the treatment of anti-NMDAR encephalitis, the heterogeneity in the treatment stratagem has not yet reported any evidence on the therapeutic option of choice when infections ensue during the immunosuppres [....] » Read More

Speaker at Brain Disorders Conference - Joao Rafael Rocha Da Silva
Oral Presentation (Virtual)
Joao Rafael Rocha Da Silva, Connect life rehabilitation and performance, Brazil

Guidelines for treating chronic low back pain are directly related to changing habits and carrying out patient-centered exercise programs, using passive resources such as manual therapy, for example, to aid treatment. In previous studies, it was possible to observe changes in [....] » Read More

Speaker at Neuroscience Conference - Ali Imran
Oral Presentation (Virtual)
Ali Imran, Government College University, Faisalabad, Pakistan

Black tea, known for its antioxidant properties, has garnered attention for its potential therapeutic effects on brain disorders. In this study, we delve into the specific role of black tea antioxidants, focusing on their compositional analysis, extraction methods, and neuroprote [....] » Read More

Speaker at Neuroscience Conference - Shazia Perveen
Oral Presentation (Virtual)
Shazia Perveen, The Women University Multan, Pakistan

Parkinson's disease (PD) is a chronic disease of the central nervous system that affects almost 1% of the elderly population. In recent years, phytocomponents have aroused considerable interest in research for PD treatment as they provide a variety of active compounds, includ [....] » Read More

Speaker at Neurology Conferences - Muskanjot Kaur
Oral Presentation (Virtual)
Muskanjot Kaur, Rowan-Virtua School of Osteopathic Medicine, United States

Background: Stroke, the second-leading cause of mortality and the third-leading cause of mortality and disability, imposes a substantial financial burden, exceeding $721 billion1. Addressing underlying causes and mitigating stroke-related consequences are crucial aspects of strok [....] » Read More

Speaker at Brain Disorders Conference - Amelia Hammersley
Oral Presentation (Virtual)
Amelia Hammersley, Oak Park and River Forest High School, United States

Traumatic brain injury (TBI) is the leading cause of death among all traumatic injuries. While there are some treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs), most cause debilitating side effects including cerebral ischemia and neurodegenerative diseases. Altern [....] » Read More

Speaker at Brain Disorders Conference - Mark Knights
Oral Presentation (Virtual)
Mark Knights, Great Western Hospital, United Kingdom

Glioblastoma’s are the most common type of primary brain tumour in adults and are the most lethal and least successfully treated solid tumours. Recently, research into the area of stem cells in brain tumour development has gained moment. However, due to the relatively new a [....] » Read More

Speaker at Neurology Conferences - Shahryar Zainaee
Poster Presentation (Virtual)
Shahryar Zainaee, Bowling Green State University, United States

Introduction: Swallowing is a fundamental physiological process for individual health and survival. The cerebellum has an integral function in regulating motor control and coordination; however, its specific role in swallowing physiology remains poorly characterized in humans. Th [....] » Read More

Speaker at Brain Disorders Conference - Jyotirmaya Jain
Poster Presentation (Virtual)
Jyotirmaya Jain, University of North Texas Health Science Center, United States

Hirayama Disease, also known as Monomelic Amyotrophy (MMA), is a lower motor neuron disease that typically presents with an insidious onset of muscle weakness and atrophy most commonly in the upper limbs including the thenar, hypothenar, and forearm muscles.9 Neurologic sensation [....] » Read More

Speaker at Brain Disorders Conference - Mark Kenneth Gonnad
Poster Presentation (Virtual)
Mark Kenneth Gonnad, Baguio General Hospital, Philippines

Introduction: Different neurologic manifestations have been observed during the Coronavirus disease (COVID-19) pandemic. However, only a handful cases of Guillain Barre syndrome (GBS) in a COVID-19 patient have been reported. No case has been reported in the Philippines. This rep [....] » Read More

Speaker at Neurology Conferences - Saeid Bagheri Mohammadi
Poster Presentation (Virtual)
Saeid Bagheri Mohammadi, Mazandaran University of Medical Sciences, Iran (Islamic Republic of)

Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder after Alzheimer’s disease and is expected to impose an increasing social and economic burden on societies as populations age. The ground-breaking developments in stem cell resear [....] » Read More